ArticleCureus2026
Use of Aprotinin in a Patient With a Renal Transplant for Redo Coronary Artery Bypass Graft Surgery.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a high-risk redo coronary artery bypass graft (CABG) surgery performed on a 58-year-old patient admitted with a non-ST-segment elevation myocardial infarction (NSTEMI) and heart failure. The patient's medical history is significant for previous mechanical aortic valve replacement due to aortic stenosis, prior CABG, and closure of a patent foramen ovale (PFO). Additional comorbidities include type I diabetes mellitus, a history of right temporo-parietal ischaemic stroke, fatty liver disease, monoclonal gammopathy of unknown significance (MGUS), and renal transplantation. In this case, aprotinin infusion was utilised intraoperatively to manage perioperative bleeding. We focused on evaluating the effects of aprotinin on renal function and postoperative renal indices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.